CS Paper Radar

scDEFT: A deep learning framework for drug-effect prediction and counterfactual reasoning

Murthy Devarakonda

cs.LG q-bio.QM ·submitted 2026-09-09 21:02 UTC · v1

Abstract

Longitudinal single cell atlases now capture matched pre treatment and post treatment states from responders and non responders, presenting an opportunity to mechanistically explain why two patients on the same drug diverge. We introduce scDEFT (single cell Drug EFfect Transducer), which treats a drug as a conditioning operator on cell representations, enabling prediction and explanation. In scDEFT, feature wise linear modulation produces drug conditioned cell latents, learned under abundant per cell supervision and then frozen. Two independent heads aggregate those latents over shared transcriptional neighborhoods to predict drug induced state change and responder status. A backward stage ranks the latent dimensions by how strongly they separate responders from non responders and maps them to genes under a cell composition control. On a harmonized inflammatory bowel disease atlas of 1.16 million cells, three cohorts and two drug classes, scDEFT predicts state change at 45% of the baseline to reproducibility ceiling headroom and stratifies responders before treatment at AUROC 0.70, where standard predictors remain at chance. These predictions and the drivers behind them support target and co target nomination, patient stratification, and counterfactual prediction of unseen drug cohort effects.

Comment
21 Pages, 5 Figures, 3 Tables, and a Supplementary Notes section for overflow material. Approximately 3000 words (excluding Figures, Tables, and Captions)

Closest papers

Nearest neighbours by meaning across the whole index.

PerturbRx: Learning Treatment-Conditioned Latent Transitions for Patient Drug Response Prediction

cs.LG q-bio.QM ·2026-08-21 ·Yoshitaka Inoue, Minoh Jeong, Alfred Hero, Rui Kuang, Augustin Luna
similarity 0.70
Abstract

Scarce data and tumor heterogeneity limit patient-level cancer treatment-response prediction. Existing approaches predict response from pretreatment molecular profiles and drug representations, without explicitly modeling the molecular changes expected under treatment. We propose PerturbRx, a treatment-conditioned representation learning framework that learns intervention-induced latent transitions and uses them as patient-drug response features. PerturbRx trains a drug- and dose-conditioned transition predictor from context-matched but cell-unpaired control and treated single-cell populations, then freezes and transfers the predictor to pretreatment patient profiles without requiring post-treatment measurements. The transition is combined with patient and drug representations to predict response. Across TCGA and patient-derived xenograft benchmarks, PerturbRx achieves the strongest aggregate predictive performance among the evaluated methods. These results support perturbation-pretrained latent transitions as useful representations for patient-level drug-response prediction.

0.25

CellCanon: An Agentic Cellular World Model for Prediction, Explanation, and Observation-Driven Updating

cs.AI q-bio.QM ·2026-11-04 ·Zhaokang Liang, Shuyang Zhuang, Xiaoran Jiao, Hao Chen
benchmarkcode/datahot direction similarity 0.69
Abstract · 31 pages, 5 figures. Code: https://github.com/ZhaokangLiang123/CellCanon

Biological discovery requires using molecular knowledge and new measurements to infer responses beyond the conditions already observed. We introduce CellCanon, the first agentic cellular world model to unify single-cell expression prediction, evidence-grounded explanation, and observation-driven updating. Its predictive core reuses condition-level biological evidence across gene-specific numerical readouts to guide single-cell expression generation. A shared world state links predictions, acquired measurements, and source-linked claims, supporting explanation and revision. On 339 held-out SciPlex3 conditions across three cell lines, CellCanon improves differential-expression AUPRC and Macro-F1 over the best baseline for each metric by 63.3% and 17.3%, respectively, and direction Macro-F1 by 7.2%. Relative to gene-wise reasoning on matched drug-cell cohorts, measured language-model token use falls by 99.77% for Predict and 98.41% for Explain. On the source-grounded benchmark, Explain correctly answers all answerable questions with supporting proofs and identifies all insufficient-evidence cases. In simulated experimental feedback, Update uses one measured source context per drug to exceed the best fine-tuned baselines in differential-expression AUPRC and Macro-F1 without changing model weights. Together, these capabilities support a cumulative account of cellular responses, with predictions and biological judgments that can be revised as evidence accumulates.

0.36

Transcriptome-informed multi-modal AI for predicting neoadjuvant therapy response from breast cancer biopsies

cs.AI ·2026-10-02 ·Jungkyu Park, Dhruva Biswas, Joseph Cappadona, Cerise Tang, Ken G. Zeng +20 more
similarity 0.68
Abstract

Scarcity of labeled data limits development of deep learning biomarkers in oncology. We develop a two-stage AI model predicting pathological complete response (pCR) to neoadjuvant therapy in breast cancer. The first stage learns the transcriptome from histopathology using 8,742 patients across 32 cancer types, corroborated by pathologist review and spatial agreement with measured expression. This simplifies the second stage to predicting pCR from inferred expression and clinical variables. Developed using 1,080 patients (five cohorts) and evaluated in 1,412 patients (nine cohorts), the model achieves a pooled AUROC of 0.79 (95% CI, 0.73-0.85), discriminating responders within molecular subtypes. It outperforms histopathological biomarkers, remaining stable across intratumoral sampling and with minimal biopsy tissue. Ablations show transcriptome-wide inference improves discrimination over clinical variables alone or one-stage pathology models, and robustness by avoiding genomic assays' gene selection constraints. These results indicate that biologically informed compression may generalize to data-sparse applications in precision oncology.

0.06

CellChain: Benchmarking Cross-Scale Evidence Use for Perturbation Reasoning

cs.DB q-bio.GN ·2026-10-12 ·Xue Xia, Yue Wang, Shuizhou Chen, Lang Yu, Hao Wu +4 more
benchmark similarity 0.67
Abstract · 21 pages, 6 figures

Recent advances in foundation models and large-scale cellular perturbation datasets have driven growing interest in using LLMs to predict and reason about cellular responses. Biological reasoning in this setting involves relating molecular mechanisms, cellular responses, and functional outcomes across scales. Evaluating foundation models therefore requires assessing not only whether their predictions are correct, but also how those predictions depend on the biological evidence provided. We introduce CellChain, an experimentally grounded benchmark comprising 590 biological cases and 2,360 matched evidence-condition instances across gene-dependency prediction, cytokine-axis identification, and drug-sensitivity ranking. CellChain links perturbation experiments and external biological resources through a provenance-aware evidence graph spanning molecular, pathway, transcriptional, and phenotypic information. Task-specific conditions vary evidence coverage, composition, or assignment while preserving questions, candidate answers, reference targets, and scoring rules. Across 18 foundation models, the highest accuracies under prespecified target-evidence conditions are 57.5%, 75.5%, and 70.8%, respectively, and broader evidence coverage does not consistently improve accuracy. On the drug-sensitivity benchmark cohort, matched reference histories outperform swapped histories by an average of 13.0 percentage points in cluster-weighted accuracy. Decision-transition analysis separates corrections, newly introduced errors, and wrong-answer switches, revealing substantial answer changes hidden by small net accuracy differences. CellChain provides controlled comparisons for attributing changes in model predictions to prespecified expansions of biological context, including changes in evidence coverage, composition, and biological assignment.

0.19

Attribution-based diagnostics for single-cell foundation models

cs.LG q-bio.QM ·2026-11-02 ·Farnoush Rezaei Jafari, Tristan Lazard, Kenza Bouzid, Shruthi Bannur, Jeremiah Wander +4 more
hot direction similarity 0.66
Abstract

Single-cell RNA foundation models (scFMs) are increasingly used for in-silico biological discovery, yet predictive performance alone does not reveal whether their decisions rely on biologically meaningful signals or model-specific shortcuts. We systematically investigate post-hoc attribution of downstream predictions across two tasks: cell-type annotation using pretrained Cell2Sentence and scGPT models, and perturbation prediction using scGPT+STATE in a controlled setting. For cell annotation, we use attribution to assess whether predictions rely on established marker genes and how their relevance varies with model architecture, expression rank, and the surrounding cellular context. For perturbation prediction, we compare attribution patterns with known regulatory ground-truth in a synthetic setting to assess what they reveal about the model's learned computations. Across these tasks, attribution reveals biological feature use, contextual interactions, contributions from different input pathways, learning progression, associations with prediction quality, and potential pitfalls that are not fully captured by standard performance metrics. Experiments with complete and limited regulatory knowledge further demonstrate that conclusions drawn from attribution depend strongly on the choice of biological reference, baseline, and null model. Together, these findings highlight the value of attribution as a flexible post-hoc diagnostic for understanding model behavior, identifying potential issues, and informing the development of scFMs.

0.24

PerturbJEPA: Joint-Embedding Predictive Learning of Cellular Perturbation Responses

cs.CV ·2026-11-16 ·Jiangshuan Pang, Youzhe He, Yiting Deng, Wangyang Tang, Huinan Xu +3 more
code/data similarity 0.66
Abstract · 23 pages, 6 figures, 14 tables. Code: https://github.com/BGI-Hangzhou-OmicsAI/PerturbJEPA

Identifying the drug and dose that produced a cellular response requires preserving treatment effects within each cellular background. A joint-embedding predictor can match its targets while ignoring the intervention if its encoder preserves differences across backgrounds but erases differences between treated and control populations within each one. We call this failure interventional contrast collapse. PerturbJEPA encodes the difference in mean gene expression between treated and control populations as an effect vector. It aligns the displacement between their latent centroids with this vector and regularizes the vectors to preserve variation across population pairs. We show that the measured displacements cannot all coincide within a batch when effect-vector variation exceeds the root-mean-square alignment error. Trained with separate drug and dose ranking objectives, the model predicts candidate responses from a common control population and matches them to the observed response without cell pairing or expression reconstruction. We evaluate 3,592 Tahoe-100M queries on held-out combinations of known interventions and cellular backgrounds, each with over 700 drug-dose candidates in a fixed, background-specific catalog. PerturbJEPA achieves 91.46% macro joint drug-dose Recall@1, exceeding STATE by 3.40 percentage points (95% drug-cluster bootstrap interval of 1.72 to 5.07 points). Controlled diagnostics show that treatment-control differences can shrink even when representations remain globally dispersed. With the drug ranking objective fixed, adding effect-vector regularization to alignment raises joint Recall@1 from 18.57% to 87.47%.

0.54

JEPA-Anything: Learning Predictive Models across Different Worlds

cs.CL ·2026-09-17 ·Taoyong Cui, Zhongyao Wang, Xinyue Xu, Weiyang Liu, Zhaochen Yu +8 more
code/datahighly cited similarity 0.66
Abstract · Code: https://github.com/Gen-Verse/JEPA-Anything

World modeling enables intelligence to anticipate consequences, guide interventions, and learn from interaction. Yet predictive models remain domain-specific: can a common learning principle support world modeling across radically different systems? We introduce JEPA-Anything, a domain-agnostic framework based on orthogonal predictive factorization (OPF). Extending joint-embedding predictive architectures, OPF decomposes latent targets into complementary factors, learns them through dedicated pathways, and recombines them within a shared predictive design. We evaluate JEPA-Anything across seven domains: vision, biology, clinical trajectories, control, molecular dynamics, physical fields, and weather. Experiments span representation learning, intervention prediction, out-of-distribution generalization, and long-horizon dynamics, including 10 matched dynamics tasks, forecasting of over 1,000 clinical events, and 100-step molecular rollouts across four systems. Against matched JEPA baselines, JEPA-Anything improves reported metrics on all 10 dynamics tasks and reduces single-intervention prediction error on Interventional Pong by 34.8%. It achieves the lowest one-step and 100-step molecular errors among compared methods in all four systems. Beyond prediction, a factor-nominated biological intervention receives experimental support in cell co-cultures, patient-derived organoids, tumor fragments, and mice; latent orbital modes recover the Keplerian scaling exponent with a fitted slope of -1.4991. These results support a common factorized predictive principle across heterogeneous worlds, connecting world modeling with intervention and experimentally grounded scientific discovery. Code: https://github.com/Gen-Verse/JEPA-Anything

0.50

Forecasting Patient Trajectories from the Electronic Health Records with Action-Conditioned World Models

cs.LG ·2026-08-16 ·Simon A. Lee, Jiahang Hank Sha, Soomin Chung, Kai Akamatsu, Eran Halperin +1 more
similarity 0.64
Abstract

We introduce a predictive world model for electronic health records (EHR) that represents patient histories as action conditioned latent trajectories. Rather than modeling clinical events solely through autoregressive token prediction, our framework explicitly separates patient states from observed clinical actions and learns their evolution through a state and action conditioned transition operator. At its core is a state dependent linearization predictor that propagates local changes in latent patient state, enabling time resolved prediction, multi step rollout, and action conditioned simulation. Empirically, we show that generated latent trajectories preserve downstream predictive signal, temporal structure, and subgroup level statistical relationships present in encoder derived representations. We further decode free running rollouts into the original clinical feature space and evaluate future clinical measurements against observed values using task matched forecasting baselines, demonstrating that the learned dynamics retain predictive information beyond latent space agreement. Across binary classification and time to event tasks, EHR WM achieves competitive, though task dependent, performance relative to substantially larger EHR foundation models while using a 30x smaller parameter footprint. Finally, perturbing observed action sequences produces corresponding changes in generated trajectories, demonstrating the action sensitivity of the learned dynamics. Together, these results support world modeling as a complementary framework for learning explicit, time indexed representations of patient evolution from longitudinal EHR.

0.34